Group
Median Survival(day)
Increased Survival(%T/C)
Control
12
100
Doxil®
29
259±23
PEGADRIA
27
241±33
%T/C: (100 × Survival of Treatment / Survival of Control); Data represent Mean±SD, (N=7)
Table 3:
Efficacy of PEGADRIA and Doxil® in P388-bearing leukemic CD2F1 mice. Median survival and increased survival.
